Rachel P. Riechelmann

Dona Adma Jafet St
Sao Paulo, SP 01308050, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications

Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors.

Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors.

Journal: ESMO gastrointestinal oncology
Published: May 29, 2026

Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter.

Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 01, 2026

The outcomes of elderly patients with localized squamous-cell carcinoma of the anal canal treated with chemoradiation.

The outcomes of elderly patients with localized squamous-cell carcinoma of the anal canal treated with chemoradiation.

Journal: ESMO gastrointestinal oncology
Published: April 17, 2026

Beyond Convenience: Does Subcutaneous Pembrolizumab Add Value for Patients and Health Systems?

Beyond Convenience: Does Subcutaneous Pembrolizumab Add Value for Patients and Health Systems?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2026

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.

Journal: Endocrine-related cancer
Published: January 28, 2026

Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas.

Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas.

Journal: Endocrine-related cancer
Published: January 28, 2026

Spiritual needs and quality of life of cancer patients.

Spiritual needs and quality of life of cancer patients.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 11, 2025

Neoadjuvant therapy versus upfront surgery followed by adjuvant chemotherapy in resectable or borderline resectable PDAC: a systematic review and meta-analysis of RCTs.

Neoadjuvant therapy versus upfront surgery followed by adjuvant chemotherapy in resectable or borderline resectable PDAC: a systematic review and meta-analysis of RCTs.

Journal: Therapeutic advances in medical oncology
Published: October 25, 2025

Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review.

Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review.

Journal: Cancers
Published: October 15, 2025

The East and West consolidated efficacy of radioligand therapy in neuroendocrine tumors.

The East and West consolidated efficacy of radioligand therapy in neuroendocrine tumors.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 17, 2025

Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy.

Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy.

Journal: Endocrine pathology
Published: September 13, 2025

Alkylating-induced hypermutation in pancreatic neuroendocrine tumours.

Alkylating-induced hypermutation in pancreatic neuroendocrine tumours.

Journal: BMJ oncology
Published: July 28, 2025
Showing 1-12 of 140

Last Updated: 09/26/2026